Dr. Agarwal's Health Care Share News - Latest Updates, Live News & More

Latest news about Dr. Agarwal's Health Care

Dr. Agarwal's Health Care: Promoter Group Plans Inter-Se Share Transfer of 14.41 Lakh Shares 3 hrs ago Today

Dr. Agarwal's Health Care Limited has announced a planned inter-se share transfer within its promoter group, with Dr. Athiya Agarwal set to acquire 14,41,568 shares (0.46%) from Dr. Anosh Agarwal on March 13, 2026. The transaction will be executed as a gift between immediate relatives under SEBI SAST Regulation 10(1)(a)(i) exemption, requiring no monetary consideration. Post-transfer, Dr. Athiya Agarwal's holding will increase from 4.00% to 4.45%, while Dr. Anosh Agarwal's stake will decrease from 4.69% to 4.23%, with no change to overall promoter group shareholding.

Dr. Agarwal's Health Care: Formal Disclosure Filed for Inter-se Share Transfer 2 days ago

Dr. Athiya Agarwal Files Regulatory Report for Completed 0.47% Stake Acquisition 10 days ago

Dr. Agarwal's Health Care receives credit rating reaffirmation and assignment from ICRA Limited Feb 23, 2026

Dr. Agarwal's Eye Hospital Receives BSE Approval for Amalgamation Scheme Feb 17, 2026

More news about Dr. Agarwal's Health Care

28Jan 26

Dr. Agarwal's Health Care Q3 Net Profit Surges 51% to ₹337m on Strong Revenue Growth

Dr. Agarwal's Health Care delivered exceptional Q3FY26 performance with consolidated net profit jumping 51% to ₹337m and revenue reaching ₹5.3b, up from ₹4.3b year-on-year. The company demonstrated strong operational efficiency with EBITDA of ₹1.4b and improved margins at 27.17%. The healthcare chain expanded its network to 272 facilities and performed over 81,000 surgeries during the quarter.

03Jan 26

Dr. Agarwal's Health Care sees promoter shareholding change through inter-se transfer

Dr. Agarwal's Health Care Limited has completed an inter-se transfer of 5,12,473 equity shares between promoter group members, with Dr. Amar Agarwal acquiring shares from Dr. Adil Agarwal through a gift transaction. The transfer, executed on December 31, 2025, increased Dr. Amar Agarwal's shareholding from 4.29% to 4.46%, representing a 0.16% increase in his voting rights while maintaining the overall promoter group shareholding structure.

12Dec 25

Dr. Agarwal's Health Care Allots 3.38 Lakh ESOP Shares, Capital Rises to ₹31.68 Cr

Dr. Agarwal's Health Care Limited has successfully allotted 3,37,504 equity shares to employees under its ESOP scheme 2022, with shares exercised at ₹135 each. This latest allotment has increased the company's paid-up equity share capital to ₹31.68 crores, demonstrating continued employee participation in the company's growth.

17Nov 25

Dr. Agarwal's Health Care Seeks Shareholder Approval for New Statutory Auditor

Dr. Agarwal's Health Care Limited initiates postal ballot for appointing M/s. S.R. Batliboi & Associates LLP as new statutory auditors, replacing Deloitte Haskins & Sells. This change aligns with pre-merger activities involving subsidiary Dr. Agarwal's Eye Hospital Limited. E-voting period set from November 18 to December 17, with proposed auditor fee of ₹52.50 lakh for the upcoming financial year. The move aims to streamline audit processes across the group post-merger.

13Nov 25

Dr. Agarwal's Health Care Announces Change in Statutory Auditors

Dr. Agarwal's Health Care Limited's Board has approved S.R. Batliboi & Associates LLP as new statutory auditors, replacing Deloitte Haskins & Sells. The change, effective November 12, 2025, aims to align auditors with the company's listed material subsidiary as part of an ongoing merger process. The appointment is subject to shareholder approval via postal ballot. S.R. Batliboi & Associates LLP will hold office until the conclusion of the 16th Annual General Meeting.

05Nov 25

Dr. Agarwal's Health Care Reports 88% PAT Growth in H1 FY26, Crosses INR 1,000 Crore Revenue Mark

Dr. Agarwal's Health Care Limited reported robust financial results for H1 FY26. Total income reached INR 1,007.00 crores, up 20.20% YoY. EBITDA grew 24.90% to INR 285.00 crores, with margin improving to 28.30%. PAT surged 88.40% to INR 75.00 crores. The company expanded its network to 258 facilities across 239 locations, serving over 14.3 lakh patients and performing nearly 157,000 surgeries. Specialized surgical procedures saw significant growth, with high-end cataract surgeries up 41.70% and robotic cataract surgeries increasing 69.00%. The Southern Region contributed 64% of total revenues. The company plans to launch 30 more facilities in the remaining quarters of FY26.

30Oct 25

Dr. Agarwal's Health Care Reports Strong H1 FY2026 Performance, Grants Stock Options, and Efficiently Utilizes IPO Proceeds

Dr. Agarwal's Health Care Limited reported robust financial results for H1 FY2026. Total Income increased by 20.2% to INR 1,007.00 crores, EBITDA grew 24.9% to INR 285.00 crores, and PAT soared 88.4% to INR 75.00 crores. The company expanded its network to 258 facilities, adding 24 new centers. It efficiently utilized IPO proceeds, with INR 257.00 crores out of INR 300.00 crores used. The company also approved new stock option grants and allotted shares under its Employee Stock Option Scheme.

30Oct 25

Dr. Agarwal's Health Care Reports Strong H1 FY2026 Results with 88% PAT Growth

Dr. Agarwal's Health Care Limited, India's largest eye care service chain by revenue, reported robust financial performance for H1 FY2026. Total income reached ₹1,007.00 crores, up 20.20% YoY. EBITDA increased 24.90% to ₹285.00 crores with a 28.30% margin. PAT soared 88.40% to ₹75.00 crores. The company expanded its network to 258 eye care facilities, adding 24 new centers in H1. It performed 157,281 surgeries, up 14.60% YoY, and served over 14 lakh patients. The company now operates across 10 countries.

29Aug 25

Dr Agarwal's Health Care and Eye Hospital Announce Merger Amidst Share Price Decline

Dr. Agarwal's Health Care Ltd. (AHCL) and Dr. Agarwal's Eye Hospital (AEHL) have approved a merger, with AEHL merging into AHCL. The merger terms include AHCL issuing 23 new equity shares for every two AEHL shares. AHCL currently holds a 71.9% stake in AEHL. Additionally, AHCL's board approved a preferential share issue worth ₹70.00 crore at ₹5,270.00 per share. Despite the merger news, both companies' share prices declined on Thursday. Morgan Stanley maintains an 'Overweight' rating on AHCL with a price target of ₹494.00, citing potential operational streamlining and enhanced shareholder value.

27Aug 25

Dr. Agarwal's Health Care and Eye Hospital Announce Merger, Aim for Operational Synergies

Dr. Agarwal's Health Care Limited (AHCL) and Dr. Agarwal's Eye Hospital Limited (AEHL) have approved a merger scheme. AHCL will issue 23 equity shares for every 2 AEHL shares. AHCL reported a standalone turnover of ₹1,043.89 crore, while AEHL's was ₹397.15 crore. AHCL will acquire additional AEHL shares worth ₹70.00 crore, increasing its stake to 72.67%. The merger aims to streamline operations, improve financial efficiency, and enhance shareholder value. Mr. Ankur Nand Thadani will join AHCL's Board as a Non-Executive Director.

16Aug 25

Dr. Agarwal's Health Care Reports Robust Q1 FY26 Results with 22% Revenue Growth and Doubled Profits

Dr. Agarwal's Health Care Limited reported impressive Q1 FY26 results. Total income rose 22.3% to INR 501.00 crores, with operational revenue up 20.8%. EBITDA grew 28.9% to INR 141.00 crores, and profit after tax more than doubled to INR 38.00 crores. The company served over 7 lakh patients, performed 78,882 surgeries, and added 13 new facilities, including entry into the Delhi market. High-end cataract surgeries increased, with robotic procedures growing 72% year-on-year. The company now has 249 facilities across India and plans to open 42 more in the next three quarters.

14Aug 25

Dr. Agarwal's Health Care Reports Full Compliance in IPO Proceeds Utilization for Q1 FY2026

Dr. Agarwal's Health Care Limited's monitoring agency report confirms full compliance with IPO fund utilization for Q2 2025. The company raised Rs. 300 crore, netting Rs. 272.47 crore. Rs. 257 crore has been utilized across loan repayment (Rs. 195 crore), general corporate purposes (Rs. 49.66 crore), and issue-related expenses (Rs. 12.34 crore). The remaining Rs. 43 crore is deployed in fixed deposits earning 5.50% to 6.55%. The company reports on-schedule progress for loan repayment and general corporate purposes utilization.

21Mar 25

Dr. Agarwal's Health Care Expands Footprint with New Branch in Mumbai's Dombivli

Dr. Agarwal's Health Care has opened a new branch in Dombivli, Mumbai, as part of its strategic expansion in the Mumbai metropolitan area. This move aims to enhance healthcare accessibility in the region and tap into the growing market. The expansion is expected to improve access to quality healthcare services for the local community and potentially increase the company's market share in Mumbai's competitive healthcare sector.